PMA

P080013: DURASEAL EXACT SPINE SEALANT SYSTEM

FDA PMA · Sealant, dural · Integra LifeSciences Corporation

Key facts

PMA number P080013
Trade name DURASEAL EXACT SPINE SEALANT SYSTEM
Generic name Sealant, dural
Applicant Integra LifeSciences Corporation
Owner/operator Integra LifeSciences Corporation
Product code NQR
Approval date Sep 4, 2009
Docket number 09M-0485
Notice date Oct 6, 2009
Establishment registration 1121308
FEI number 1121308

At a glance

  • 10–99 Supplements
  • Feb 27, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals